Russell Investments Group
BBNX

Russell Investments Group’s Beta Bionics BBNX Stock Holding History

Russell Investments Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$237K Sell
23,681
-182,156
-88% -$2.69M ﹤0.01% 2796
2025
Q4 		$6.27M Buy
205,837
+111,610
+118% +$2.98M 0.01% 1173
2025
Q3 		$1.87M Buy
94,227
+93,412
+11,462% +$1.64M ﹤0.01% 1897
2025
Q2 		$11.9K Buy
+815
New +$11.5K ﹤0.01% 3298

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Russell Investments Group's BBNX Position: Q1 2026 in Review

Russell Investments Group reduced its Beta Bionics (BBNX) stake by 88% in Q1 2026, selling an estimated $2.69M and leaving 23,681 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #2796.

Russell Investments Group first reported a position in BBNX in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.27M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Russell Investments Group held 23,681 shares of Beta Bionics worth $237K as of Q1 2026.
  • Russell Investments Group sold 182,156 Beta Bionics shares in Q1 2026, an estimated $2.69M.
  • Beta Bionics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2796 holding.
  • Russell Investments Group first reported a position in Beta Bionics in Q2 2025 and has held it in 4 quarters since.
  • Russell Investments Group's Beta Bionics position peaked at $6.27M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.